Relationship between inflammation and tissue hypoxia in a mouse model of chronic colitis

Inflammatory Bowel Diseases

Volumn 17, Issue 3, 2011, Pages 742-746

  Harris, Norman R ^a   Carter, Patsy R ^a   Yadav, Amit Singh ^a   Watts, Megan N ^a   Zhang, Songlin ^a   Kosloski Davidson, Melissa ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

colitis; Crohn's Disease; hematocrit; hypoxia; vascular density

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; OXYGEN; PIMONIDAZOLE; RAG1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC COLITIS; COLITIS; COLON BLOOD FLOW; CONTROLLED STUDY; GOBLET CELL; HEMATOCRIT; HISTOPATHOLOGY; HYPOXEMIA; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE OXYGENATION;

ADOPTIVE TRANSFER; ANIMALS; ANOXIA; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COLITIS; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE;

EID: 79951603925     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21423     Document Type: Article

References (14)

1. Hatoum OA, Binion DG, Otterson MF, et al. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology. 2003; 125: 58-69. (Pubitemid 36799107)
2. Thornton M, Solomon MJ,. Crohn's disease: in defense of a microvascular aetiology. Int J Colorectal Dis. 2002; 17: 287-297. (Pubitemid 36067762)
3. Karhausen J, Furuta GT, Tomaszewski JE, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest. 2004; 114: 1098-1106. (Pubitemid 39578699)
4. Robinson A, Keely S, Karhausen J, et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology. 2008; 134: 145-155. (Pubitemid 350309309)
5. Harris NR, Carter PR, Lee S, et al. Association between blood flow and inflammatory state in a T-cell transfer model of inflammatory bowel disease in mice. Inflamm Bowel Dis. 2010; 16: 776-782.
6. Rennick DM, Fort MM, Davidson NJ,. Studies with IL-10-/- mice: an overview. J Leukoc Biol. 1997; 61: 389-396.
7. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116: 1310-1316.
8. Ostanin DV, Bao J, Koboziev I, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G135-146.
9. Lee S, Carter PR, Watts MN, et al. Effects of the endothelin-converting enzyme inhibitor SM-19712 in a mouse model of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2009; 15: 1007-1013.
10. Hulten L, Lindhagen J, Lundgren O, et al. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology. 1977; 72: 388-396. (Pubitemid 8036711)
11. Kruschewski M, Foitzik T, Perez-Canto A, et al. Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci. 2001; 46: 2336-2343. (Pubitemid 33042330)
12. Kruschewski M, Anderson T, Buhr HJ, et al. Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis. Dig Dis Sci. 2006; 51: 662-670.
13. Kruschewski M, Anderson T, Loddenkemper C, et al. Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats. Dig Dis Sci. 2006; 51: 1461-1470. (Pubitemid 44321673)
14. Shah YM, Ito S, Morimura K, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology. 2008; 134: 2036-2048.